Monash IVF Group Ltd
0.45
EUR
0.00
(0.00%)
Monash IVF Group Ltd
FRA:MIS
(Frankfurt Stock Exchange)
Recent
price
0.45
P/E
ratio
- -
div
yld
6.56%
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- Monash IVF Group Limited (ASX:MVF) operates as a leading provider of assisted reproductive services and specialist women's imaging in Australia and Malaysia. The company offers a comprehensive range of fertility treatments including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo freezing, genetic testing, and egg donor programs; diagnostic obstetric and gynaecological ultrasound services; and tertiary level prenatal diagnostics delivered through a network of clinics featuring specialists, sonographers, scientists, nurses, and counsellors. Founded in 2008 through the acquisition of Repromed in South Australia and the Northern Territory, the group expanded via the 2009 purchase of Monash IVF in Victoria and Queensland, the 2012 acquisition of KL Fertility in Malaysia, and more recent additions of Fertility East in Sydney and Sydney Ultrasound for Women; it maintains headquarters in Cremorne, Victoria, and supports ongoing research through the Monash IVF Group Research and Education Foundation. In recent developments, the company rejected a $312 million opportunistic acquisition proposal from a consortium including Soul Patts in November 2025, continues international expansion in Southeast Asia with five clinics operational by fiscal 2023, and reports a 13.4% increase in clinical pregnancy rates since 2018 alongside steady dividend payments.
Company News
Memphasys signs national supply agreement with Monash IVF for Felix sperm selection system
Monash IVF Group (ASX:MVF) Insider Sells A$53,925.00 in Stock